Literature DB >> 17441924

Prognostic factors in renal cell cancer.

Won-Ho Park1, Tim Eisen.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17441924     DOI： 10.1111/j.1464-410X.2007.06828.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  9 in total

1.  Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes.

Authors:  T H Ho; D J Serie; M Parasramka; J C Cheville; B M Bot; W Tan; L Wang; R W Joseph; T Hilton; B C Leibovich; A S Parker; J E Eckel-Passow
Journal:  Ann Oncol       Date:  2017-03-01       Impact factor: 32.976

2.  SLC18A3 promoted renal cancer development through acetylcholine/cAMP signaling.

Authors:  Peng Tie; Ji Cheng; Miao-Xin Xue; Jian Yin; Guo Fu; Wan-Li Duan
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

3.  Clinical symptoms related to renal cell carcinoma are independent prognostic factors for intraoperative complications and overall survival.

Authors:  Attila Szendroi; Adám Tabák; Peter Riesz; Miklós Szucs; Peter Nyírády; Attila Majoros; Gabriel Haas; Imre Romics
Journal:  Int Urol Nephrol       Date:  2009-03-13       Impact factor: 2.370

4.  Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma--does it affect survival?

Authors:  Andrew A Stec; Benjamin J Coons; Sam S Chang; Michael S Cookson; S Duke Herrell; Joseph A Smith; Peter E Clark
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

5.  Prognostic factors and survival of renal clear cell carcinoma patients with bone metastases.

Authors:  Attila Szendroi; Elek Dinya; Magdolna Kardos; A Marcel Szász; Zsuzsanna Németh; Katalin Ats; János Kiss; Imre Antal; Imre Romics; Miklós Szendroi
Journal:  Pathol Oncol Res       Date:  2009-07-29       Impact factor: 3.201

6.  Identification of KIF23 as a Prognostic Biomarker Associated With Progression of Clear Cell Renal Cell Carcinoma.

Authors:  Zonglong Wu; Yimeng Song; Yaqian Wu; Liyuan Ge; Zhuo Liu; Tan Du; Shudong Zhang; Lulin Ma
Journal:  Front Cell Dev Biol       Date:  2022-04-11

7.  Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma.

Authors:  Lucile Broncy; Basma Ben Njima; Arnaud Méjean; Christophe Béroud; Khaled Ben Romdhane; Marius Ilie; Veronique Hofman; Jane Muret; Paul Hofman; Habiba Chaabouni Bouhamed; And Patrizia Paterlini-Bréchot
Journal:  Oncotarget       Date:  2018-04-13

Review 8.  Circulating Tumor Cells for the Management of Renal Cell Carcinoma.

Authors:  Lucile Broncy; Patrizia Paterlini-Bréchot
Journal:  Diagnostics (Basel)       Date:  2018-09-03

9.  Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma.

Authors:  L Campbell; B Jasani; K Edwards; M Gumbleton; D F R Griffiths
Journal:  Br J Cancer       Date:  2008-02-19       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.